| Filed On | Filing |
|---|---|
| 03 Jan 2025 |
Form 3: Fortress Biotech, Inc., 10% owner
Holds 6,552,784 shares of COMMON STOCK, PAR VALUE $0.0001 |
| 29 Oct 2024 |
Form 3: Jin David, Director
Holds 1,994 shares of Common Stock |
| 12 Feb 2024 |
Form 3: Murphy James B, Interim CFO
No securities owned |
| 19 Dec 2023 |
Form 3: Carney Peter, See Remarks
Holds 3,992 shares of Common Stock |
| 07 Jun 2022 |
Form 3: Lurier Eliot M, Interim CFO
Holds 0 shares of Common Stock |
| 29 Apr 2020 |
Form 3: Zelefsky Michael J, Director
Holds 73,812 shares of Common Stock |
| 27 Nov 2018 |
Form 3: Achenbach Brian, VP, Fin. & Corp. Controller
Holds 0 shares of Common Stock |
| 20 Jul 2017 |
Form 3: Rosenwald Lindsay A Md, Director
Holds 10,000 shares of Common Stock (Restricted) |
| 30 Jun 2017 |
Form 3: Weiss Michael S, Exec. Chairman of the Board
Holds 60,000 shares of Common Stock (Restricted) |
| 30 Jun 2017 |
Form 3: Litchman Manuel Md, Director
Holds 0 shares of Common Stock (Restricted) |
| 30 Jun 2017 |
Form 3: Horin David J, Interim CFO
Holds 0 shares of Common Stock (Restricted) |
| 30 Jun 2017 |
Form 3: Chill Adam J., Director
Holds 50,000 shares of Common Stock (Restricted) |
| 30 Jun 2017 |
Form 3: Herskowitz Neil, Director
Holds 50,000 shares of Common Stock (Restricted) |
| 07 Jun 2017 |
Form 3: Fortress Biotech, Inc., 10% owner
Holds 9,000,000 shares of Common Stock, par value $0.0001 |
Loading...